Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
3.660
-0.290 (-7.34%)
At close: Oct 2, 2026, 4:00 PM EDT
3.680
+0.020 (0.55%)
After-hours: Oct 2, 2026, 7:59 PM EDT
Jaguar Health Revenue
Jaguar Health had revenue of $1.23M in the quarter ending June 30, 2026, a decrease of -58.88%. This brings the company's revenue in the last twelve months to $27.82M, up 135.52% year-over-year. In the year 2025, Jaguar Health had annual revenue of $11.51M, down -1.52%.
Revenue (ttm)
$27.82M
Revenue Growth
+135.52%
P/S Ratio
0.07
Revenue / Employee
$591,809
Employees
47
Market Cap
1.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.51M | -178.00K | -1.52% |
| Dec 31, 2024 | 11.69M | 1.93M | 19.75% |
| Dec 31, 2023 | 9.76M | -2.20M | -18.36% |
| Dec 31, 2022 | 11.96M | 7.62M | 175.80% |
| Dec 31, 2021 | 4.34M | -5.05M | -53.81% |
| Dec 31, 2020 | 9.39M | 3.61M | 62.51% |
| Dec 31, 2019 | 5.78M | 1.36M | 30.77% |
| Dec 31, 2018 | 4.42M | 54.96K | 1.26% |
| Dec 31, 2017 | 4.36M | 4.22M | 2,981.61% |
| Dec 31, 2016 | 141.52K | -116.86K | -45.23% |
| Dec 31, 2015 | 258.38K | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Curis | 4.31M |
| Silo Pharma | 54.08K |
| Virax Biolabs Group | 12.42K |
| Alaunos Therapeutics | 3.00K |
| Valion Bio | -86.00K |
JAGX News
- 17 hours ago - Jaguar Health Announces a Special Stock Dividend - Accesswire
- 4 days ago - Jaguar Health Proxy statement: Proxy filing - Filings
- 4 days ago - Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting - Accesswire
- 11 days ago - Jaguar Health receives fee waivers from FDA - TheFly
- 11 days ago - Jaguar Health Receives Fee Waivers from FDA - Accesswire
- 15 days ago - Jaguar Health Proxy statement: Proxy filing - Filings
- 18 days ago - Jaguar Health announces 1-for-15 reverse stock split - TheFly
- 18 days ago - Jaguar Health, Inc. Announces Reverse Stock Split - Accesswire